Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study

V. Klimek,J. E. Schenck,Hui Han,C. Stockmeier,G. Ordway

DOI: https://doi.org/10.1016/S0006-3223(02)01383-5

IF: 12.81

2002-10-01

Biological Psychiatry

Abstract:

What problem does this paper attempt to address?

Of criminals and cancer: The importance of social bonds and innate morality on cellular societies

Anuraag Bukkuri,Frederick R Adler

DOI: https://doi.org/10.1016/j.cdev.2024.203964

2024-08-14

Abstract:The current dogma in cancer biology contends that cancer is an identity problem: mutations in a cell's DNA cause it to "go rogue" and proliferate out of control. However, this largely ignores the role of cell-cell interaction and fails to explain phenomena such as cancer reversion, the existence of cancers without mutations, and foreign-body carcinogenesis. In this proof-of-concept paper, we draw on criminology to propose that cancer may alternatively be conceptualized as a relational problem: Although a cell's genetics is essential, the influence of its interaction with other cells is equally important in determining its phenotype. We create a simple agent-based network model of interactions among normal and cancer cells to demonstrate this idea. We find that both high mutation rates and low levels of connectivity among cells can promote oncogenesis. Viewing cancer as a breakdown in communication networks among cells in a tissue complements the gene-centric paradigm nicely and provides a novel perspective for understanding and treating cancer.
Evolving models of tumor origin and progression

Iwona Mitrus,Ewa Bryndza,Aleksander Sochanik,Stanisław Szala

DOI: https://doi.org/10.1007/s13277-012-0389-0

2012-04-11

Tumor Biology

Abstract:History of cancer disease models clearly illustrates the evolving nature of these concepts. Since such models undergo continual revisions and additions as a result of underlying medical research, they also tend to reorganize knowledge and allow perceiving previously unseen relationships. Growth of medical thought has been influenced for many centuries by an ancient Hippocratic concept of disease seen as a disturbance in bodily “humors.” True mechanisms of cell and tissue injury started to be elucidated only with the advent of postmortem pathological findings. Concerning cancer, when first disease-producing bacteria were identified in the nineteenth century, also neoplasms were treated as infectious diseases. Foreign organisms were thought to be present inside tumors. However, this hypothesis could not be confirmed by microscopic or histochemical studies. The latter suggested, instead, that tumors were rather formed by abnormal cells. Cancer was then started to be regarded as a disease of cells. This interpretation was radically altered by later developments in genetics which suggested that neoplasms can be treated as genetic diseases as pathologic cellular lesions are caused by mutations in specific genes. More recent models have compared carcinogenesis to evolutionary processes. Due to genetic instability, successive mutations, appearing in cells, lead to selection of cancer cells which feature specific phenotypic traits. The newest data indicate that there may be also a link between cancer and mutated stem cells. The review discusses main concepts of tumor origin forwarded since the beginnings of the nineteenth century.
Reconciling Non-Genetic Plasticity with Somatic Evolution in Cancer

Sui Huang

DOI: https://doi.org/10.1016/j.trecan.2020.12.007

Abstract:Post-treatment progression of tumors is commonly explained by somatic Darwinian evolution (i.e., selection of cells carrying genetic mutations that create more aggressive cell traits). But cancer genome and transcriptome analyses now paint a picture far more complex, prompting us to see beyond the Darwinian scheme: non-genetic cell phenotype plasticity explained by alternative stable gene expression states ('attractors'), may also produce aggressive phenotypes that can be selected for, without mutations. Worse, treatment may even induce cell state transitions into more malignant attractors. We review recent evidence for non-genetic mechanisms of progression, explain the theoretical foundation of attractor transitions behind treatment-induced increase of aggressiveness, and provide a framework for unifying genetic and non-genetic dynamics in tumor progression.
Spatial model predicts dispersal and cell turnover cause reduced intra-tumor heterogeneity

Bartlomiej Waclaw,Ivana Bozic,Meredith E. Pittman,Ralph H. Hruban,Bert Vogelstein,Martin A. Nowak

DOI: https://doi.org/10.48550/arXiv.1503.07116

2015-03-24

Populations and Evolution

Abstract:Most cancers in humans are large, measuring centimeters in diameter, composed of many billions of cells. An equivalent mass of normal cells would be highly heterogeneous as a result of the mutations that occur during each cell division. What is remarkable about cancers is their homogeneity - virtually every neoplastic cell within a large cancer contains the same core set of genetic alterations, with heterogeneity confined to mutations that have emerged after the last clonal expansions. How such clones expand within the spatially-constrained three dimensional architecture of a tumor, and come to dominate a large, pre-existing lesion, has never been explained. We here describe a model for tumor evolution that shows how short-range migration and cell turnover can account for rapid cell mixing inside the tumor. With it, we show that even a small selective advantage of a single cell within a large tumor allows the descendants of that cell to replace the precursor mass in a clinically relevant time frame. We also demonstrate that the same mechanisms can be responsible for the rapid onset of resistance to chemotherapy. Our model not only provides novel insights into spatial and temporal aspects of tumor growth but also suggests that targeting short range cellular migratory activity could have dramatic effects on tumor growth rates.
Abstract PR016: Topology of the tumor microenvironment: Integrating imaging, modeling, and topological data analysis

Rowan Barker-Clarke,Jason M. Gray,Jacob G. Scott

DOI: https://doi.org/10.1158/1538-7445.canevol23-pr016

IF: 11.2

2024-02-02

Cancer Research

Abstract:Cancer evolution involves multiple stochastic processes across many scales. In addition to genomic and transcriptomic changes, hallmarks of cancer within solid tumors include the malignant co-evolution of the tumor microenvironment. Although the evaluation of tissue architecture plays a key role in pathologist staging, the automated extraction of additional structural features remains far from translation to the clinic. However, one particularly effective novel methodology for extracting patterns from these clinical images is topological data analysis(TDA). TDA is a field that studies the shape of data and its connectedness using concepts from geometric and algebraic topology. Recent work using topological data analysis has allowed the extraction of image features. Such features have been associated with clinical outcomes in both the analysis of H&E images in prostate cancer and CT images in lung cancer. We set out to question how the topological features of tissues, including tumor and stromal composition, evolve during treatment and between original sites and metastasis. To analyze this we use a combination of tissue sections, imaging, and cell-automata models and persistent homology and cubical persistence techniques from TDA. We apply certain topological methods for the first time to tissue images (H&E) and to the output of spatial simulations. We focus specifically on analyzing the evolution of topological features in ovarian and lung cancer and compare our features to 2D and 3D simulations (HAL) with varying game theoretical interactions as well as comparing features across tissues from matched primary and metastatic sites. We find that several topological features are conserved between primary and metastatic sites and some feature evolution is replicated in simulation. Citation Format: Rowan Barker-Clarke, Jason M. Gray, Jacob G. Scott. Topology of the tumor microenvironment: Integrating imaging, modeling, and topological data analysis [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier; 2023 Dec 3-6; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_2) nr PR016.

oncology
The effects of gender and age on associations between blood lipid levels and obesity in Danish men and women aged 35-65 years.

B. Heitmann

DOI: https://doi.org/10.1016/0895-4356(92)90046-P

IF: 7.407

1992-07-01

Journal of Clinical Epidemiology

Abstract:
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity

Peter Friedl,Stephanie Alexander

DOI: https://doi.org/10.1016/j.cell.2011.11.016

IF: 64.5

2011-11-01

Cell

Abstract:Cancer invasion is a cell- and tissue-driven process for which the physical, cellular, and molecular determinants adapt and react throughout the progression of the disease. Cancer invasion is initiated and maintained by signaling pathways that control cytoskeletal dynamics in tumor cells and the turnover of cell-matrix and cell-cell junctions, followed by cell migration into the adjacent tissue. Here, we describe the cell-matrix and cell-cell adhesion, protease, and cytokine systems that underlie tissue invasion by cancer cells. We explain how the reciprocal reprogramming of both the tumor cells and the surrounding tissue structures not only guides invasion, but also generates diverse modes of dissemination. The resulting "plasticity" contributes to the generation of diverse cancer invasion routes and programs, enhanced tumor heterogeneity, and ultimately sustained metastatic dissemination.

cell biology,biochemistry & molecular biology
Spatial biology of cancer evolution

Zaira Seferbekova,Artem Lomakin,Lucy R. Yates,Moritz Gerstung

DOI: https://doi.org/10.1038/s41576-022-00553-x

IF: 59.581

2022-12-10

Nature Reviews Genetics

Abstract:The natural history of cancers can be understood through the lens of evolution given that the driving forces of cancer development are mutation and selection of fitter clones. Cancer growth and progression are spatial processes that involve the breakdown of normal tissue organization, invasion and metastasis. For these reasons, spatial patterns are an integral part of histological tumour grading and staging as they measure the progression from normal to malignant disease. Furthermore, tumour cells are part of an ecosystem of tumour cells and their surrounding tumour microenvironment. A range of new spatial genomic, transcriptomic and proteomic technologies offers new avenues for the study of cancer evolution with great molecular and spatial detail. These methods enable precise characterizations of the tumour microenvironment, cellular interactions therein and micro-anatomical structures. In conjunction with spatial genomics, it emerges that tumours and microenvironments co-evolve, which helps explain observable patterns of heterogeneity and offers new routes for therapeutic interventions.

genetics & heredity
Modeling collective cell behavior in cancer: Perspectives from an interdisciplinary conversation

Abhinav Bhushan,Paul Bogdan,Jose Javier Bravo-Cordero,Amy Brock,Yun Chen,Edna Cukierman,Zev Jordan Gartner,Ginger Hunter,Mohit Kumar Jolly,Loukia Georgiou Karacosta,Karthikeyan Mythreye,Parag Katira,Herbert Levine,Emil Lou,Gerald Quon,Analiz Rodriguez,Gregory Lee Szeto,Itai Yanai,Hannah Dueck,Frederick R. Adler,Alexander R.A. Anderson,Kathleen E. DelGiorno,Gerald V. Denis,Meghan C. Ferrall-Fairbanks,Ronald N. Germain,Deborah M. Gordon,Rajan P. Kulkarni,Matthew L. Kutys,Arthur D. Lander,Ashley M. Laughney,Pedro R. Lowenstein,Kristyn S. Masters,Dana Pe’er,Shelly R. Peyton,Manu O. Platt,Jeremy E. Purvis,Jennifer K. Richer,Nicole C. Riddle,Joshua C. Snyder,Claire J. Tomlin,Ioannis K. Zervantonakis

DOI: https://doi.org/10.1016/j.cels.2023.03.002

IF: 11.091

2023-04-01

Cell Systems

Abstract:Collective cell behavior contributes to all stages of cancer progression. Understanding how collective behavior emerges through cell-cell interactions and decision-making will advance our understanding of cancer biology and provide new therapeutic approaches. Here, we summarize an interdisciplinary discussion on multicellular behavior in cancer, draw lessons from other scientific disciplines, and identify future directions.

cell biology,biochemistry & molecular biology
The Epigenetic Hallmarks of Cancer

Manel Esteller,Mark A. Dawson,Cigall Kadoch,Feyruz V. Rassool,Peter A. Jones,Stephen B. Baylin

DOI: https://doi.org/10.1158/2159-8290.cd-24-0296

IF: 28.2

2024-10-05

Cancer Discovery

Abstract:Cancer is a complex disease in which several molecular and cellular pathways converge to foster the tumoral phenotype. Notably, in the latest iteration of the cancer hallmarks, "nonmutational epigenetic reprogramming" was newly added. However, epigenetics, much like genetics, is a broad scientific area that deserves further attention due to its multiple roles in cancer initiation, progression, and adaptive nature. Herein, we present a detailed examination of the epigenetic hallmarks affected in human cancer, elucidating the pathways and genes involved, and dissecting the disrupted landscapes for DNA methylation, histone modifications, and chromatin architecture that define the disease. Significance: Cancer is a disease characterized by constant evolution, spanning from its initial premalignant stages to the advanced invasive and disseminated stages. It is a pathology that is able to adapt and survive amidst hostile cellular microenvironments and diverse treatments implemented by medical professionals. The more fixed setup of the genetic structure cannot fully provide transformed cells with the tools to survive but the rapid and plastic nature of epigenetic changes is ready for the task. This review summarizes the epigenetic hallmarks that define the ecological success of cancer cells in our bodies.

oncology
Cancer Networks: A general theoretical and computational framework for understanding cancer

Eric Werner

DOI: https://doi.org/10.48550/arXiv.1110.5865

2011-10-26

Molecular Networks

Abstract:We present a general computational theory of cancer and its developmental dynamics. The theory is based on a theory of the architecture and function of developmental control networks which guide the formation of multicellular organisms. Cancer networks are special cases of developmental control networks. Cancer results from transformations of normal developmental networks. Our theory generates a natural classification of all possible cancers based on their network architecture. Each cancer network has a unique topology and semantics and developmental dynamics that result in distinct clinical tumor phenotypes. We apply this new theory with a series of proof of concept cases for all the basic cancer types. These cases have been computationally modeled, their behavior simulated and mathematically described using a multicellular systems biology approach. There are fascinating correspondences between the dynamic developmental phenotype of computationally modeled {\em in silico} cancers and natural {\em in vivo} cancers. The theory lays the foundation for a new research paradigm for understanding and investigating cancer. The theory of cancer networks implies that new diagnostic methods and new treatments to cure cancer will become possible.
Extracting Intercellular Signaling Network of Cancer Tissues using Ligand-Receptor Expression Patterns from Whole-tumor and Single-cell Transcriptomes

Joseph X. Zhou,Roberto Taramelli,Edoardo Pedrini,Theo Knijnenburg,Sui Huang

DOI: https://doi.org/10.1038/s41598-017-09307-w

IF: 4.6

2017-08-18

Scientific Reports

Abstract:Many behaviors of cancer, such as progression, metastasis and drug resistance etc., cannot be fully understood by genetic mutations or intracellular signaling alone. Instead, they are emergent properties of the cell community which forms a tumor. Studies of tumor heterogeneity reveal that many cancer behaviors critically depend on intercellular communication between cancer cells themselves and between cancer-stromal cells by secreted signaling molecules (ligands) and their cognate receptors. We analyzed public cancer transcriptome database for changes in cell-cell interactions as the characteristic of malignancy. We curated a list (>2,500 ligand-receptor pairs) and identified their joint enrichment in tumors from TCGA pan-cancer data. From single-cell RNA-Seq data for a case of melanoma and the specificity of the ligand-receptor interactions and their gene expression measured in individual cells, we constructed a map of a cell-cell communication network that indicates what signal is exchanged between which cell types in the tumor. Such networks establish a new formal phenotype of cancer which captures the cell-cell communication structure - it may open new opportunities for identifying molecular signatures of coordinated behaviors of cancer cells as a population - in turn may become a determinant of cancer progression potential and prognosis.

multidisciplinary sciences
Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution

Yelyzaveta Shlyakhtina,Katherine L Moran,Maximiliano M Portal,Katherine L. Moran,Maximiliano M. Portal

DOI: https://doi.org/10.3390/cancers13061380

2021-03-18

Cancers

Abstract:Cancer development can be defined as a process of cellular and tissular microevolution ultimately leading to malignancy. Strikingly, though this concept has prevailed in the field for more than a century, the precise mechanisms underlying evolutionary processes occurring within tumours remain largely uncharacterized and rather cryptic. Nevertheless, although our current knowledge is fragmentary, data collected to date suggest that most tumours display features compatible with a diverse array of evolutionary paths, suggesting that most of the existing macro-evolutionary models find their avatar in cancer biology. Herein, we discuss an up-to-date view of the fundamental genetic and non-genetic mechanisms underlying tumour evolution with the aim of concurring into an integrated view of the evolutionary forces at play throughout the emergence and progression of the disease and into the acquisition of resistance to diverse therapeutic paradigms. Our ultimate goal is to delve into the intricacies of genetic and non-genetic networks underlying tumour evolution to build a framework where both core concepts are considered non-negligible and equally fundamental.

oncology
Remodeling of Stromal Cells and Immune Landscape in Microenvironment During Tumor Progression

Leena Arora,Durba Pal

DOI: https://doi.org/10.3389/fonc.2021.596798

IF: 4.7

2021-03-08

Frontiers in Oncology

Abstract:The molecular understanding of carcinogenesis and tumor progression rests in intra and inter-tumoral heterogeneity. Solid tumors confined with vast diversity of genetic abnormalities, epigenetic modifications, and environmental cues that differ at each stage from tumor initiation, progression, and metastasis. Complexity within tumors studied by conventional molecular techniques fails to identify different subclasses in stromal and immune cells in individuals and that affects immunotherapies. Here we focus on diversity of stromal cell population and immune inhabitants, whose subtypes create the complexity of tumor microenvironment (TME), leading primary tumors towards advanced-stage cancers. Recent advances in single-cell sequencing (epitope profiling) approach circumscribes phenotypic markers, molecular pathways, and evolutionary trajectories of an individual cell. We discussed the current knowledge of stromal and immune cell subclasses at different stages of cancer development with the regulatory role of non-coding RNAs. Finally, we reported the current therapeutic options in immunotherapies, advances in therapies targeting heterogeneity, and possible outcomes.

oncology
Tumor cell migration in complex microenvironments

William J. Polacheck,Ioannis K. Zervantonakis,Roger D. Kamm

DOI: https://doi.org/10.1007/s00018-012-1115-1

IF: 8

2012-08-25

Cellular and Molecular Life Sciences

Abstract:Tumor cell migration is essential for invasion and dissemination from primary solid tumors and for the establishment of lethal secondary metastases at distant organs. In vivo and in vitro models enabled identification of different factors in the tumor microenvironment that regulate tumor progression and metastasis. However, the mechanisms by which tumor cells integrate these chemical and mechanical signals from multiple sources to navigate the complex microenvironment remain poorly understood. In this review, we discuss the factors that influence tumor cell migration with a focus on the migration of transformed carcinoma cells. We provide an overview of the experimental and computational methods that allow the investigation of tumor cell migration, and we highlight the benefits and shortcomings of the various assays. We emphasize that the chemical and mechanical stimulus paradigms are not independent and that crosstalk between them motivates the development of new assays capable of applying multiple, simultaneous stimuli and imaging the cellular migratory response in real-time. These next-generation assays will more closely mimic the in vivo microenvironment to provide new insights into tumor progression, inform techniques to control tumor cell migration, and render cancer more treatable.

cell biology,biochemistry & molecular biology
A case of Sweet's syndrome and myelodysplasia: response to cyclosporin

G. Sharpe,H. Leggat

DOI: https://doi.org/10.1111/j.1365-2133.1992.tb14856.x

IF: 11.113

1992-11-01

British Journal of Dermatology

Abstract:A case of severe Sweet's syndrome associated with myelodysplasia is reported. The skin lesions responded to high doses of systemic steroids, but recurred rapidly on dose reduction. Treatment with a low dose of cyclosporin resulted in sustained clearance of the skin lesions, and was associated with a stable haemoglobin level, without the need for further blood transfusions.
Toward an Ising model of cancer and beyond

Salvatore Torquato

DOI: https://doi.org/10.1088/1478-3975/8/1/015017

2011-02-01

Physical Biology

Abstract:The holy grail of tumor modeling is to formulate theoretical and computational tools that can be utilized in the clinic to predict neoplastic progression and propose individualized optimal treatment strategies to control cancer growth. In order to develop such a predictive model, one must account for the numerous complex mechanisms involved in tumor growth. Here we review the research work that we have done toward the development of an 'Ising model' of cancer. The Ising model is an idealized statistical-mechanical model of ferromagnetism that is based on simple local-interaction rules, but nonetheless leads to basic insights and features of real magnets, such as phase transitions with a critical point. The review begins with a description of a minimalist four-dimensional (three dimensions in space and one in time) cellular automaton (CA) model of cancer in which cells transition between states (proliferative, hypoxic and necrotic) according to simple local rules and their present states, which can viewed as a stripped-down Ising model of cancer. This model is applied to study the growth of glioblastoma multiforme, the most malignant of brain cancers. This is followed by a discussion of the extension of the model to study the effect on the tumor dynamics and geometry of a mutated subpopulation. A discussion of how tumor growth is affected by chemotherapeutic treatment, including induced resistance, is then described. We then describe how to incorporate angiogenesis as well as the heterogeneous and confined environment in which a tumor grows in the CA model. The characterization of the level of organization of the invasive network around a solid tumor using spanning trees is subsequently discussed. Then, we describe open problems and future promising avenues for future research, including the need to develop better molecular-based models that incorporate the true heterogeneous environment over wide range of length and time scales (via imaging data), cell motility, oncogenes, tumor suppressor genes and cell-cell communication. A discussion about the need to bring to bear the powerful machinery of the theory of heterogeneous media to better understand the behavior of cancer in its microenvironment is presented. Finally, we propose the possibility of using optimization techniques, which have been used profitably to understand physical phenomena, in order to devise therapeutic (chemotherapy/radiation) strategies and to understand tumorigenesis itself.

biochemistry & molecular biology,biophysics
Cancer Stem Cells: an Old Idea - A Paradigm Shift

MS Wicha,SL Liu,G Dontu

DOI: https://doi.org/10.1158/0008-5472.can-05-3153

IF: 11.2

2006-01-01

Cancer Research

Abstract:Although the concept that cancers arise from "stem cells" or "germ cells" was first proposed about 150 years ago, it is only recently that advances in stem cell biology have given new impetus to the "cancer stem cell hypothesis." Two important related concepts of this hypothesis are that (a) tumors originate in either tissue stem cells or their immediate progeny through dysregulation of the normally tightly regulated process of self-renewal. As a result of this, (b) tumors contain a cellular subcomponent that retains key stem cell properties. These properties include self-renewal, which drives tumorigenesis, and differentiation albeit aberrant that contributes to cellular heterogeneity. Recent experimental evidence in a variety of tumors has lent strong support to the cancer stem cell hypothesis that represents a paradigm shift in our understanding of carcinogenesis and tumor cell biology. This hypothesis has fundamental implications for cancer risk assessment, early detection, prognostication, and prevention. Furthermore, the current development of cancer therapeutics based on tumor regression may have produced agents that kill differentiated tumor cells while sparing the rare cancer stem cell population. The development of more effective cancer therapies may thus require targeting this important cell population.
Mimicking and analyzing the tumor microenvironment

Roxane Crouigneau,Yan-Fang Li,Jamie Auxillos,Eliana Goncalves-Alves,Rodolphe Marie,Albin Sandelin,Stine Falsig Pedersen

DOI: https://doi.org/10.1016/j.crmeth.2024.100866

2024-10-21

Abstract:The tumor microenvironment (TME) is increasingly appreciated to play a decisive role in cancer development and response to therapy in all solid tumors. Hypoxia, acidosis, high interstitial pressure, nutrient-poor conditions, and high cellular heterogeneity of the TME arise from interactions between cancer cells and their environment. These properties, in turn, play key roles in the aggressiveness and therapy resistance of the disease, through complex reciprocal interactions between the cancer cell genotype and phenotype, and the physicochemical and cellular environment. Understanding this complexity requires the combination of sophisticated cancer models and high-resolution analysis tools. Models must allow both control and analysis of cellular and acellular TME properties, and analyses must be able to capture the complexity at high depth and spatial resolution. Here, we review the advantages and limitations of key models and methods in order to guide further TME research and outline future challenges.
Characterizing the Ecological and Evolutionary Dynamics of Cancer

Nastaran Zahir,Ruping Sun,Daniel Gallahan,Robert A. Gatenby,Christina Curtis

DOI: https://doi.org/10.1038/s41588-020-0668-4

IF: 30.8

2020-01-01

Nature Genetics

Abstract:This Perspective discusses the need for mechanistic and quantitative understanding of the ecological and evolutionary dynamics of tumor growth to inform strategies for earlier detection, diagnosis and treatment of cancer. Tumor initiation and progression are somatic evolutionary processes driven by the accumulation of genetic alterations, some of which confer selective fitness advantages to the host cell. This gene-centric model has shaped the field of cancer biology and advanced understanding of cancer pathophysiology. Importantly, however, each genotype encodes diverse phenotypic traits that permit acclimation to varied microenvironmental conditions. Epigenetic and transcriptional changes also contribute to the heritable phenotypic variation required for evolution. Additionally, interactions between cancer cells and surrounding stromal and immune cells through autonomous and non-autonomous signaling can influence competition for survival. Therefore, a mechanistic understanding of tumor progression must account for evolutionary and ecological dynamics. In this Perspective, we outline technological advances and model systems to characterize tumor progression through space and time. We discuss the importance of unifying experimentation with computational modeling and opportunities to inform cancer control.

Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study

Of criminals and cancer: The importance of social bonds and innate morality on cellular societies

Evolving models of tumor origin and progression

Reconciling Non-Genetic Plasticity with Somatic Evolution in Cancer

Spatial model predicts dispersal and cell turnover cause reduced intra-tumor heterogeneity

Abstract PR016: Topology of the tumor microenvironment: Integrating imaging, modeling, and topological data analysis

The effects of gender and age on associations between blood lipid levels and obesity in Danish men and women aged 35-65 years.

Cancer Invasion and the Microenvironment: Plasticity and Reciprocity

Spatial biology of cancer evolution

Modeling collective cell behavior in cancer: Perspectives from an interdisciplinary conversation

The Epigenetic Hallmarks of Cancer

Cancer Networks: A general theoretical and computational framework for understanding cancer

Extracting Intercellular Signaling Network of Cancer Tissues using Ligand-Receptor Expression Patterns from Whole-tumor and Single-cell Transcriptomes

Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution

Remodeling of Stromal Cells and Immune Landscape in Microenvironment During Tumor Progression

Tumor cell migration in complex microenvironments

A case of Sweet's syndrome and myelodysplasia: response to cyclosporin

Toward an Ising model of cancer and beyond

Cancer Stem Cells: an Old Idea - A Paradigm Shift

Mimicking and analyzing the tumor microenvironment

Characterizing the Ecological and Evolutionary Dynamics of Cancer